Why did oil prices surge after Israel's attack on Iran?
How will the Air India plane crash impact Boeing's business?
What caused Tesla to delay its robotaxi launch?
Why are Amazon and Walmart considering stablecoin issuance?
How will Fed's steady interest rates affect markets?
What is behind Meta's $14 billion investment in Scale AI?
Why did grocery workers authorize a strike in Southern California?
COVID-19 Vaccine Maker BioNTech Buys CureVac as It Aims for Cancer Treatments
finance.yahoo.com/news/covid-19-vaccine-maker-biontech-142518112.html
In This Article:
Key Takeaways
-
BioNTech is buying fellow German firm CureVac for approximately $1.25 billion as the COVID-19 vaccine maker moves to expand into cancer treatments.
-
For each CureVac share they own, investors will get about $5.46 worth of BioNTech American Depositary…
This story appeared on finance.yahoo.com, 2025-06-12 14:25:18.